August 14, 2025 · Form 4 insider transaction
Malley Thomas sold 78,233 shares of Kiniksa Pharmaceuticals Ltd. at $33.09 per share, a transaction worth $2.59M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.82 and $33.41. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.